Knockdown of Wnt/β-catenin pathway coactivator TCF4 and LEF1 in HCC cells with DDX39 overexpressing inhibited HCC progression, confirming DDX39 promoted HCC progression by activating Wnt/β-catenin pathway. The gene discussed is LEF1; the disease is hepatocellular carcinoma.